![Christopher Steer on Twitter: "Hui- Online calculator https://t.co/X7sESMwiCE Is it the https://t.co/xOY5njAIC8 for #pallonc? #MASCC18 #prognostication workshop #supponc #gerionc https://t.co/XCET9YeVh5" / Twitter Christopher Steer on Twitter: "Hui- Online calculator https://t.co/X7sESMwiCE Is it the https://t.co/xOY5njAIC8 for #pallonc? #MASCC18 #prognostication workshop #supponc #gerionc https://t.co/XCET9YeVh5" / Twitter](https://pbs.twimg.com/media/DgxFIibX4AAGnIc.jpg:large)
Christopher Steer on Twitter: "Hui- Online calculator https://t.co/X7sESMwiCE Is it the https://t.co/xOY5njAIC8 for #pallonc? #MASCC18 #prognostication workshop #supponc #gerionc https://t.co/XCET9YeVh5" / Twitter
![How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology](https://ecancer.org/en/journal/article/site/data/images/article/918/can-13-913fig10.gif)
How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology
![A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00700-x/MediaObjects/41408_2022_700_Fig1_HTML.png)
A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries
![The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease - ScienceDirect The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167814019300052-ga1.jpg)
The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease - ScienceDirect
![PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/503346139e7d62281fc955036b1fe2a70e2b4ab6/4-Table2-1.png)
PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar
Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcar
![The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers | BMC Cancer | Full Text The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-015-1526-0/MediaObjects/12885_2015_1526_Fig1_HTML.gif)
The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers | BMC Cancer | Full Text
![How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology](https://ecancer.org/en/journal/article/site/data/images/article/918/can-13-913fig6.gif)
How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology
![Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation | BMC Medical Informatics and Decision Making | Full Text Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation | BMC Medical Informatics and Decision Making | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1472-6947-13-72/MediaObjects/12911_2013_Article_692_Fig1_HTML.jpg)